A Phase I Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Conditions:   Recurrent Respiratory Papillomatosis;   Papillomavirus Infections;   Papillomaviridae Intervention:   Drug: PRGN-2012 Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials